For the Inventor, By the Inventor

Enter assignee name

Or-Akiva, Israel

Regentis Biomaterials Ltd.

USPTO Granted Patents = 12

EPO Patents = 7

Trademarks = 2

Forward Citations = 53

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Dror Seliktar (8 out of 9 patents)

Liora Almany (6 out of 6 patents)

Yonatan Shachaf (3 out of 3 patents)

4. Raz Simon (3 out of 3 patents)

5. Boaz Harari (2 out of 106 patents)

6. Amir Perle (2 out of 18 patents)

7. Aharon Wechsler (1 out of 1 patent)

8. Maya Gonen-Wadmany (1 out of 1 patent)

9. Koby Gvili (1 out of 1 patent)

10. Maya Gonen--Wadmany (0 patent)

12 patents: Sort by Forward Citations

1. 12465668 - Organic solvent free compositions comprising protein-polymer conjugates and uses thereof (2025-11-11),

2. 10434215 - Compositions comprising a polymer-protein conjugate and an environmentally-responsive polymer and uses thereof (2019-10-08),

3. 9895519 - Treatment of cavities in a human body (2018-02-20),

4. 9872705 - Treatment of cavities in a human body (2018-01-23),

5. 9700600 - Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same (2017-07-11),

6. 9624259 - Compositions and methods for scaffold formation (2017-04-18),

7. 9474830 - PEGylated fibrinogen precursor molecule (2016-10-25),

8. 9120872 - Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same (2015-09-01),

9. 8858925 - Pegylated fibrinogen precursor molecule (2014-10-14),

10. 8846020 - Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof (2014-09-30),

11. 8007774 - Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same (2011-08-30),

12. 7842667 - Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same (2010-11-30),

Regentis Biomaterials is a leading regenerative medicine company specialized in developing innovative hydrogels for tissue repair and regeneration. Their flagship product, GelrinC, is a biodegradable hydrogel designed for cartilage repair in knee joints. With its unique properties, GelrinC enables the regeneration of damaged cartilage, providing an innovative solution for patients suffering from osteoarthritis or other cartilage injuries. Regentis Biomaterials is committed to advancing the field of regenerative medicine, offering potential solutions to improve patients' quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

12 Patents

#3 in Or-Akiva

#491 in Israel

#46,630 in the World

Or-Akiva, Israel

Regentis Biomaterials Ltd.

Forward Citations = 53

10 inventors:

Dror Seliktar (8 out of 9 patents)

Liora Almany (6 out of 6 patents)

Yonatan Shachaf (3 out of 3 patents)

4. Raz Simon (3 out of 3 patents)

5. Boaz Harari (2 out of 106 patents)

Please report any incorrect information to support@idiyas.com

Loading…